Literature DB >> 10371190

Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.

M J Otero, A Fuertes, R Sánchez, G Luna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371190     DOI: 10.1097/00002030-199905280-00025

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

1.  Drug Interactions with Antiretrovirals.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

Review 2.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Authors:  R Douglas Bruce; David E Moody; Frederick L Altice; Marc N Gourevitch; Gerald H Friedland
Journal:  Expert Rev Clin Pharmacol       Date:  2013-05       Impact factor: 5.045

Review 4.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.

Authors:  S M Clarke; F M Mulcahy; J Tjia; H E Reynolds; S E Gibbons; M G Barry; D J Back
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 6.  Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems.

Authors:  Santosh Kumar; P S S Rao; Ravindra Earla; Anil Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-12-24       Impact factor: 4.481

7.  Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients.

Authors:  Hartmut Stocker; Guido Kruse; Peter Kreckel; Christian Herzmann; Keikawus Arastéh; Jörg Claus; Heiko Jessen; Christiane Cordes; Bettina Hintsche; Frank Schlote; Lothar Schneider; Michael Kurowski
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 8.  Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.

Authors:  Dhananjay Pal; Deep Kwatra; Mukul Minocha; Durga K Paturi; Balasubrahmanyam Budda; Ashim K Mitra
Journal:  Life Sci       Date:  2010-11-01       Impact factor: 5.037

Review 9.  Nevirapine: pharmacokinetic considerations in children and pregnant women.

Authors:  M Mirochnick; D F Clarke; A Dorenbaum
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

Review 10.  Interindividual variability of methadone response: impact of genetic polymorphism.

Authors:  Yongfang Li; Jean-Pierre Kantelip; Pauline Gerritsen-van Schieveen; Siamak Davani
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.